Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q2 2014 · 10-Q
Revenue$44.16M$44.16M+63.0% vs Q2 2013 Net Income$25.29M$25.29M+27.0% vs Q2 2013 EPS Diluted$0.76$0.76+7.0% vs Q2 2013 Operating Income$25,577,000+32.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin57.9%−13.2 pt vs Q2 2013
Net margin57.3%−16.3 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 4, 2014 · 35 d after period end